文献
J-GLOBAL ID:201902262546962144
整理番号:19A2039609
非小細胞肺癌におけるファーストラインのペンブロリムマブ対ペムブロリムマブ+化学療法対化学療法単独:系統的レビューとネットワークMeta-分析【JST・京大機械翻訳】
First-line Pembrolizumab Versus Pembrolizumab Plus Chemotherapy Versus Chemotherapy Alone in Non-small-cell Lung Cancer: A Systematic Review and Network Meta-analysis
著者 (13件):
Kim Ryul
(Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
,
Keam Bhumsuk
(Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
,
Keam Bhumsuk
(Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea)
,
Hahn Seokyung
(Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Korea)
,
Hahn Seokyung
(Department of Medicine, Seoul National University College of Medicine, Seoul, Korea)
,
Ock Chan-Young
(Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
,
Kim Miso
(Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
,
Kim Tae Min
(Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
,
Kim Tae Min
(Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea)
,
Kim Dong-Wan
(Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
,
Kim Dong-Wan
(Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea)
,
Heo Dae Seog
(Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
,
Heo Dae Seog
(Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea)
資料名:
Clinical Lung Cancer
(Clinical Lung Cancer)
巻:
20
号:
5
ページ:
331-338.e4
発行年:
2019年
JST資料番号:
W3210A
ISSN:
1525-7304
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)